Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Walter P. Weber, MD
University Hospital, Basel, Switzerland
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
62 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical University of Vienna
Vienna, Austria
- University Hospital Ghent
Ghent, Belgium
- Sirio-Libanes Hospital, Department of Oncology
Brasília, Brazil
- Nossa Senhora Das Gracias Hospital
Curitiba, Brazil
- Instituto de Mastologia E Oncologia
Goiânia, Brazil
- Santa Paula Hospital
São Paulo, Brazil
- Sirio-Libanes Hospital, Department of Oncology
São Paulo, Brazil
- Mc Gill University
Montreal, Canada
- Universitätsklinikum Augsburg
Augsburg, Germany
- University Hospital Düsseldorf
Düsseldorf, Germany
- Kem Evang. Kliniken Essen-Mitte
Essen, Germany
- University Hospital Heidelberg
Heidelberg, Germany
- University Hospital Schleswig-Holstein Campus Lübeck
Lübeck, Germany
- German Breast Group
Neu-Isenburg, Germany
- Athens Medical Center
Athens, Greece
- Heraklion University Hospital
Heraklion, Greece
- Sheba Medical Center
Tel Litwinsky, Israel
- Instituto Nazionale Tumori (irccs)
Naples, Italy
- University of Naples Federico
Naples, Italy
- Veneto Institute of Oncology Irccs
Padua, Italy
- Istituti Clinici Scientifici Maugeri Irccs,
Pavia, Italy
- Irccs Humanitas Research Hospital
Rozzano, Italy
- Antoni Van Leeuwenhoek
Amsterdam, Netherlands
- University Hospital of Zielona Góra
Zielona Góra, Poland
- Institute of Oncology Ljubljana
Ljubljana, Slovenia
- Asan Medical Center
Seoul, South Korea
- Gangnam Severance Hospital
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Hospital del Mar
Barcelona, Spain
- Sahlgrenska University Hospital Gothenburg
Gothenburg, Sweden
- University Hospital Basel
Basel, Canton of Basel-City, Switzerland
- Kantonsspital Baden
Baden, Switzerland
- Breastcenter Zürich
Zurich, Switzerland
- University Hospital Zürich
Zurich, Switzerland
- Gülhane Research and Training Hospital
Ankara, Turkey (Türkiye)
- Acıbadem Research Instıtute of Senology
Istanbul, Turkey (Türkiye)
- Istanbul University Institute of Oncology
Istanbul, Turkey (Türkiye)
- Istanbul University, Faculty of Medicine
Istanbul, Turkey (Türkiye)
- Marmara University, School of Medicine
Istanbul, Turkey (Türkiye)
- Zonguldak Bulent Ecevit University
Zonguldak, Turkey (Türkiye)
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 May 2023
- Primary completion
- 31 Dec 2023
- Completion
- 31 Dec 2024
- Last update posted
- 20 Jan 2025
- Registered enrollment
- 583
- Registry id
- NCT06464341
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.